Group One Trading’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,427
Closed -$55K 3720
2022
Q1
$55K Buy
+13,427
New +$55K ﹤0.01% 1409
2021
Q4
Hold
0
3660
2021
Q3
Sell
-47,520
Closed -$207K 3584
2021
Q2
$207K Buy
47,520
+5,233
+12% +$22.8K ﹤0.01% 1109
2021
Q1
$174K Buy
42,287
+6,130
+17% +$25.2K ﹤0.01% 1072
2020
Q4
$144K Buy
36,157
+23,144
+178% +$92.2K ﹤0.01% 941
2020
Q3
$35K Buy
13,013
+947
+8% +$2.55K ﹤0.01% 1143
2020
Q2
$33K Sell
12,066
-24,942
-67% -$68.2K ﹤0.01% 996
2020
Q1
$87K Buy
37,008
+11,520
+45% +$27.1K ﹤0.01% 722
2019
Q4
$120K Sell
25,488
-2,850
-10% -$13.4K ﹤0.01% 764
2019
Q3
$95K Sell
28,338
-2,063
-7% -$6.92K ﹤0.01% 756
2019
Q2
$100K Sell
30,401
-37,682
-55% -$124K ﹤0.01% 686
2019
Q1
$206K Buy
68,083
+33,037
+94% +$100K ﹤0.01% 508
2018
Q4
$95K Sell
35,046
-14,214
-29% -$38.5K ﹤0.01% 755
2018
Q3
$166K Buy
49,260
+47,511
+2,716% +$160K ﹤0.01% 696
2018
Q2
$5K Sell
1,749
-8,935
-84% -$25.5K ﹤0.01% 1213
2018
Q1
$24K Sell
10,684
-4,573
-30% -$10.3K ﹤0.01% 1005
2017
Q4
$30K Buy
15,257
+14,757
+2,951% +$29K ﹤0.01% 1036
2017
Q3
$2K Sell
500
-1,300
-72% -$5.2K ﹤0.01% 1230
2017
Q2
$6K Buy
+1,800
New +$6K ﹤0.01% 1179
2017
Q1
Sell
-300
Closed -$1K 1997
2016
Q4
$1K Sell
300
-5,155
-95% -$17.2K ﹤0.01% 1225
2016
Q3
$9K Hold
5,455
﹤0.01% 1022
2016
Q2
$6K Sell
5,455
-2,000
-27% -$2.2K ﹤0.01% 1039
2016
Q1
$6K Buy
7,455
+2,533
+51% +$2.04K ﹤0.01% 1045
2015
Q4
$6K Sell
4,922
-104,200
-95% -$127K ﹤0.01% 1221
2015
Q3
$186K Sell
109,122
-14,558
-12% -$24.8K ﹤0.01% 605
2015
Q2
$257K Buy
123,680
+70,637
+133% +$147K ﹤0.01% 543
2015
Q1
$144K Buy
53,043
+12,300
+30% +$33.4K ﹤0.01% 591
2014
Q4
$105K Sell
40,743
-5,654
-12% -$14.6K ﹤0.01% 693
2014
Q3
$85K Buy
46,397
+7,377
+19% +$13.5K ﹤0.01% 783
2014
Q2
$104K Sell
39,020
-65,253
-63% -$174K ﹤0.01% 700
2014
Q1
$365K Sell
104,273
-29,587
-22% -$104K 0.01% 402
2013
Q4
$600K Buy
133,860
+21,751
+19% +$97.5K 0.01% 320
2013
Q3
$455K Buy
112,109
+4,890
+5% +$19.8K 0.01% 335
2013
Q2
$446K Buy
+107,219
New +$446K 0.01% 299